Skip to content

Impact of Surgery Timing on Outcomes after Gallbladder Removal in Patients with Bile Duct Stones

Evaluation of the effect of the timing of interval laparoscopic cholecystectomy on intra-operative and post-operative outcomes of patients with choledocholithiasis. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/096819
Enrollment
26
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Intervention2: NIL: Observational trial Control Intervention1: NIL: Observational trial

Sponsors

Datta Meghe Institue Of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All individuals between 18 to more than 65 years of age with choledocholithiasis and cholelithiasis diagnosed on the basis of ultrasonography, CECT or MRCP All individuals undergoing interval cholecystectomy after ERCP stenting. All individuals who come under ASA grade 1 and 2. All individuals with choledocholithiasis with or without cholelithiasis with or without cholangitis who underwent ERCP stenting, cholecystectomy and stent removal. All individuals who are consenting for study.

Exclusion criteria

Exclusion criteria: All individuals who lost to follow up. Failure of CBD stone clearance during ERCP. Malignancy or primary sclerosing cholangitis. Patients with Severe liver or kidney dysfunction Patients who underwent previous upper abdominal surgeries. Patients who are unfit for general anaesthesia Patients who underwent cholecystectomy before ERCP Patients who have Mirizzi syndrome All individuals who are not consenting.

Design outcomes

Primary

MeasureTime frame
This study will help to determine optimal timing between ERCP stenting and interval cholecystectomy in order to improve the intra-operative and post operative outcomes and to reduce the risk of recurrent biliary events.Timepoint: 2 years

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Swati Deshpande

JawaharLal Nehru Medical College DMIHER

dswat86@gmail.com9969274572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026